BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adhoute X, Pénaranda G, Raoul JL, Edeline J, Blanc JF, Pol B, Campanile M, Perrier H, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Le Treut YP, Bronowicki JP, Bourlière M. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World J Gastroenterol 2017; 23(14): 2545-2555 [PMID: 28465639 DOI: 10.3748/wjg.v23.i14.2545]
URL: https://www.wjgnet.com/1948-5182/full/v23/i14/2545.htm
Number Citing Articles
1
David Thayer, Christopher Noda, Resmi Charalel, Abigail Mills, Randy Chang, Yu Tao, Olaguoke Akinwande. Survival comparison of hepatocellular carcinoma patients treated with radioembolization versus nonoperative/interventional treatmentJournal of Comparative Effectiveness Research 2018; 7(4): 343 doi: 10.2217/cer-2017-0064
2
Dirk Andreas Ridder, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Lana Urbansky, Hagen Roland Witzel, Stefan Heinrich, Wilfried Roth, Beate Katharina Straub. Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular CarcinomaCancers 2021; 13(4): 744 doi: 10.3390/cancers13040744
3
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver diseaseJournal of the Chinese Medical Association 2021;  doi: 10.1097/JCMA.0000000000000530
4
Alonso Heriberto Ramírez-Sánchez, Iván Eliud Casanova-Sánchez, Sergio Esquivel-Torres, Alma Yrani Escobar-Ríos, Gustavo Martínez-Mier. Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, MéxicoCirujano General 2021; 43(1): 23 doi: 10.35366/103910
5
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski, Devalingam Mahalingam. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)Cancers 2019; 11(8): 1085 doi: 10.3390/cancers11081085
6
Amit G. Singal, Neehar D. Parikh, Nicole E. Rich, Binu V. John, Anjana Pillai. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 27 doi: 10.1007/978-3-030-21540-8_2
7
Sophia Heinrich, Martin Sprinzl, Irene Schmidtmann, Elena Heil, Sandra Koch, Carolin Czauderna, Bernd Heinrich, Laurence Philippe P Diggs, Marcus‐Alexander Wörns, Roman Kloeckner, Peter R Galle, Jens U Marquardt, Arndt Weinmann. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsUnited European Gastroenterology Journal 2020; 8(4): 444 doi: 10.1177/2050640620904524
8
Chia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, Cheng-Yuan Hsia, Praneeth Kudaravalli, Yun-Hsuan Lee, Yi-You Chiou, Ya-Ju Tsai, Yi-Hsiang Huang, Teh-Ia Huo. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinomaBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4202-3
9
Xavier Adhoute, Edouard Larrey, Guillaume Pénaranda, Rodolphe Anty. ALBI‐based BCLC nomogram: A new or an additional prognostic tool?Liver International 2020; 40(7): 1785 doi: 10.1111/liv.14431
10
Jiarui Yang, Shuguang Zhu, Juanjuan Yong, Long Xia, Xiangjun Qian, Jiawei Yang, Xueqiao Hu, Yuxuan Li, Chusi Wang, Wenguang Peng, Lei Zhang, Meihai Deng, Weidong Pan. A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal ValidationFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.616976
11
María Pipa-Muñiz, Susana Sanmartino, Alicia Mesa, Carmen Álvarez-Navascués, Maria-Luisa González-Diéguez, Valle Cadahía, José-Eduardo Rodríguez, Florentino Vega, Manuel Rodríguez, Serafin-Marcos Costilla-García, María Varela. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolizationBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01307-x
12
Kazunari Tanaka, Kunihiko Tsuji, Takeshi Matsui, Jong‐Hon Kang, Yasuo Sakurai, Yoshihisa Kodama, Ryosuke Minami, Kiichi Watanabe, Akio Katanuma. Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver diseaseJGH Open 2022; 6(1): 36 doi: 10.1002/jgh3.12705
13
V. A. Vishnevsky, Kh. A. Ayvazyan, R. Z. Ikramov, D. A. Ionkin, O. I. Zhavoronkova, Yu. A. Stepanova, A. B. Varava, Yu. A. Kovalenko, Yu. O. Zharikov, A. B. Goncharov, A. A. Olifir, A. Yu. Pakhomova, S. A. Bugaev, A. V. Zhao. Modern principles of hepatocellular carcinoma treatmentAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 15 doi: 10.16931/1995-5464.2020215-26
14
Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu. Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancerNanoscale 2018; 10(33): 15677 doi: 10.1039/C8NR03927E
15
Bernhard Scheiner, Gregor Ulbrich, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Fredrik Waneck, Michael Trauner, Claus Kölblinger, Arnulf Ferlitsch, Wolfgang Sieghart, Markus Peck-Radosavljevic, Matthias Pinter. Short‐ and long‐term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinomaUnited European Gastroenterology Journal 2019; 7(6): 850 doi: 10.1177/2050640619840199
16
Soumya Jogi, Radha Varanai, Sravani S. Bantu, Ashish Manne. Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelinesOncology Reviews 2020; 14(2) doi: 10.4081/oncol.2020.515